The Effectiveness of Self-Management Education and Telephone Follow-up in Patient with COPD Exacerbation
1 other identifier
interventional
150
1 country
1
Brief Summary
According to the 2024 GOLD guidelines, Chronic Obstructive Pulmonary Disease (COPD) is defined as heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production, and/or exacerbations) due to abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction. COPD is one of the leading causes of mortality and morbidity in Turkey and worldwide. Since COPD is an incurable and lifelong disease, it is important for patients to have high levels of self-management. The main questions it aims to answer are:
- Level of self-care agency
- Level of symptom management The results obtained will be interpreted by comparing between 3 groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 25, 2024
CompletedFirst Posted
Study publicly available on registry
November 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedNovember 27, 2024
September 1, 2024
1.1 years
November 25, 2024
November 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
mMRC Dyspnea Scale
It is used to rate the effects of breathlessness in daily activities. The scale was developed and modified by the British Medical Research Council (MRC) to determine the course of breathlessness in respiratory diseases. The MMRC is a five-item scale based on various movements that cause shortness of breath.
will be re-administered in the pre-test and interviews with patients at 1, 3 and 6 months
The COPD Assessment Test
The Turkish reliability and validity of the scale, which consists of eight questions to assess health status in COPD, was conducted by Yorgancıoğlu et al. in 2012. The COPD Assessment Test provides assessment of conditions such as sputum, shortness of breath, cough, fatigue, and sleep. Each question is scored between 0 (no symptoms) and 5 (severe symptoms). The scores of the questions in the test are between "0-40". The higher the score, the more severe the disease and the worse the health status.
will be re-administered in the pre-test and interviews with patients at 1, 3 and 6 months
Clinical COPD Questionnaire (CCQ)
It is a 10-item questionnaire (4 items for symptoms, 4 items for functional status and 2 items for mental status) that measures clinical control to assess functional status, mental status and symptoms and is valid and reliable in Turkish.
will be re-administered in the pre-test and interviews with patients at 1, 3 and 6 months
The Modified Borg Dyspnea Scale
The Modified Borg Dyspnea Scale was developed by Borg in 1970 to measure the effort expended during exercise and the level of dyspnea felt at the maximum level at which exercise has to be stopped. The severity of dyspnea on the scale is expressed by ten items defined from "0 (none)" to "10 (very severe)". The severity of exertion during exercise is graded according to this scoring to determine the level of dyspnea.
will be re-administered in the pre-test and interviews with patients at 1, 3 and 6 months
Secondary Outcomes (1)
Self-Care Agency
will be re-administered in the pre-test and interviews with patients at 1, 3 and 6 months
Study Arms (3)
Education+Telephone Follow-up
EXPERIMENTALPatients in this group will receive self-management education during the 3 days when they are in the hospital. On the first day of the training, COPD disease, causes of the disease, symptoms, reasons for alleviating complaints, practical information for living comfortably with COPD will be given. On the second day, emergency situations in COPD, what is an exacerbation and prevention suggestions and diaphragmatic breathing-cough exercises will be taught. On the last day, training will be given on pursed lip breathing, medication use, oxygen and nebulizer treatments. Patients will receive their first call one week after discharge. The calls will be scheduled weekly during the first month, biweekly in the second month, and monthly starting from the third month. During the calls, it is planned to repeat the educational content and answer the patient's questions. All scales are planned to be re-administered at 1, 3, and 6 months.
Education
EXPERIMENTALPatients in this group will receive self-management education during the 3 days when they are in the hospital. On the first day of the training, COPD disease, causes of the disease, symptoms, reasons for alleviating complaints, practical information for living comfortably with COPD will be given. On the second day, emergency situations in COPD, what is an exacerbation and prevention suggestions and diaphragmatic breathing-cough exercises will be taught. On the last day, training will be given on puckered lip breathing, medication use, oxygen and nebulizer treatments. Patients in this group will not receive telephone follow-up. All scales are planned to be re-administered at 1, 3, and 6 months.
Standard Care
ACTIVE COMPARATORPatients in this group will receive standard care. Education and telephone follow-up will not be applied. All scales are planned to be re-administered at 1, 3, and 6 months.
Interventions
Patients in this group will receive self-management education during the 3 days when they are in the hospital. On the first day of the training, COPD disease, causes of the disease, symptoms, reasons for alleviating complaints, practical information for living comfortably with COPD will be given. On the second day, emergency situations in COPD, what is an exacerbation and prevention suggestions and diaphragmatic breathing-cough exercises will be taught. On the last day, training will be given on pursed lip breathing, medication use, oxygen and nebulizer treatments. The education will be accompanied by a educational booklet prepared by researchers and expert opinion.
Patients will receive their first call one week after discharge. The calls will be scheduled weekly during the first month, biweekly in the second month, and monthly starting from the third month. During the calls, it is planned to repeat the educational content and answer the patient's questions.
Eligibility Criteria
You may qualify if:
- Diagnosed with COPD for the last 1 year
- Diagnosis of Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage III or IV COPD documented by pulmonary function testing
- Patients hospitalized for acute exacerbation of COPD;
- Hospitalized for at least 3 days
- Having a personal mobile phone and the ability to use it,
- Being enough conscious and oriented to answer the questions,
- Voluntary patients
You may not qualify if:
- Under 18 years old
- Withdrawal from the study at any phase
- Inability to be contacted by phone/mobile phone,
- Patient death
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kirsehir Training and Research Hospital
Kırşehir, 40200, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yasemin CEYHAN, PhD
Kirsehir Ahi Evran Universitesi
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Proffesor
Study Record Dates
First Submitted
November 25, 2024
First Posted
November 27, 2024
Study Start
September 1, 2024
Primary Completion
October 1, 2025
Study Completion
October 1, 2025
Last Updated
November 27, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share